Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,264 | -130,932 | -99,250 | -68,501 | -37,513 |
| Depreciation Amortization | 2,964 | 8,739 | 5,832 | 2,980 | 1,236 |
| Accounts payable and accrued liabilities | -2,954 | -4,788 | -3,155 | -3,861 | -1,503 |
| Other Working Capital | -3,978 | 123,945 | 121,354 | 120,941 | 120,462 |
| Other Operating Activity | 6,013 | 17,088 | 12,178 | 9,638 | 4,071 |
| Operating Cash Flow | $-29,219 | $14,052 | $36,959 | $61,197 | $86,753 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 36,329 | 17,476 | 15,481 | -16,995 | -39,970 |
| PPE Investments | -4,991 | -30,604 | -24,336 | -14,524 | -4,067 |
| Investing Cash Flow | $31,338 | $-13,128 | $-8,855 | $-31,519 | $-44,037 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 448 | 27,158 | 27,063 | 26,926 | 26,878 |
| Financing Cash Flow | $448 | $27,158 | $27,063 | $26,926 | $26,878 |
| Beginning Cash Position | 86,244 | 58,162 | 58,162 | 58,162 | 58,162 |
| End Cash Position | 88,811 | 86,244 | 113,329 | 114,766 | 127,756 |
| Net Cash Flow | $2,567 | $28,082 | $55,167 | $56,604 | $69,594 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,219 | 14,052 | 36,959 | 61,197 | 86,753 |
| Capital Expenditure | -4,991 | -30,604 | -24,336 | -14,524 | -4,067 |
| Free Cash Flow | -34,210 | -16,552 | 12,623 | 46,673 | 82,686 |